Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH:cytochrome c (P-450) reductase.
- 9 January 1996
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 93 (1) , 456-460
- https://doi.org/10.1073/pnas.93.1.456
Abstract
Purified NADPH:cytochrome c (P-450) reductase (FpT; NADPH-ferrihemoprotein oxidoreductase, EC 1.6.2.4) can reductively activate mitomycin antibiotics through a one-electron reduction to species that alkylate DNA. To assess the involvement of FpT in the intracellular activation of the mitomycins, transfectants overexpressing a human FpT cDNA were established from a Chinese hamster ovary cell line deficient in dihydrofolate reductase (CHO-K1/dhfr-). The parental cell line was equisensitive to the cytotoxic action of mitomycin C under oxygenated and hypoxic conditions. In contrast, porfiromycin was considerably less cytotoxic to wild-type parental cells than was mitomycin C in air and markedly more cytotoxic under hypoxia. Two FpT-transfected clones were selected that expressed 19- and 27-fold more FpT activity than the parental line. Levels of other oxidoreductases implicated in the activation of the mitomycins were unchanged. Significant increases in sensitivity to mitomycin C and porfiromycin in the two FpT-transfected clones were seen under both oxygenated and hypoxic conditions, with the increases in toxicity being greater under hypoxia than in air. These findings demonstrate that FpT can bioreductively activate the mitomycins in living cells and implicate FpT in the differential aerobic/hypoxic toxicity of the mitomycins.Keywords
This publication has 42 references indexed in Scilit:
- Characterization of a human bladder cancer cell line selected for resistance to mitomycin CInternational Journal of Cancer, 1994
- Studies on the mechanism of the cytotoxic action of the mitomycin antibiotics in hypoxic and oxygenated EMT6 cellsAdvances in Enzyme Regulation, 1993
- Diversity of penetration of anti‐cancer agents into solid tumoursCell Proliferation, 1991
- Randomized clinical trial of mitomycin c as an adjunct to radiotherapy in head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Generation of hydroxyl radical by anticancer quinone drugs, carbazilquinone, mitomycin C, aclacinomycin A and adriamycin, in the presence of NADPH-cytochrome P-450 reductaseBiochemical Pharmacology, 1982
- Metabolic activation of mitomycin C by liver microsomes and nucleiBiochemical Pharmacology, 1982
- Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugsBiochimica et Biophysica Acta (BBA) - General Subjects, 1980
- The hypoxic tumor cell: A target for selective cancer chemotherapyBiochemical Pharmacology, 1980
- One-electron-transfer reactions in biochemical systems III. One-electron reduction of quinones by microsomal flavin enzymesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1969
- AN ELECTRON-TRANSPORT SYSTEM ASSOCIATED WITH THE OUTER MEMBRANE OF LIVER MITOCHONDRIAThe Journal of cell biology, 1967